The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review
Brain Sciences – May 26, 2025
Source: OpenAlex
Summary
Psilocybin, a hallucinogen and alkaloid often produced via chemical synthesis, offers significant promise for Traumatic Brain Injury (TBI) recovery. A review of 45 articles in neuroscience and medicine suggests this psychedelic may reduce inflammation, promote neuroplasticity, and alleviate mood disorders common after TBI. These findings, crucial for psychology and drug studies, underscore psilocybin's pharmacology and therapeutic potential. Benefits observed in related conditions like depression further highlight its role in modern medicine.
Abstract
Background: This narrative review explores psilocybin’s potential use as a therapeutic agent in patients with traumatic brain injury (TBI). Methods: We engaged in a search of PubMed, ScienceDirect, and Cochrane’s databases for information on the effects of psilocybin. We also reviewed articles where psilocybin was used in patients with TBI. Articles from 2000–2025 were included. Results: A total of 29 articles met our initial inclusion criteria. Additionally, 13 articles were obtained from reference lists and 3 more articles on the legality of psilocybin from public websites. Conclusions: Assisted psilocybin use may have benefits in TBI by reducing inflammation, promoting neuroplasticity and neuroregeneration, and alleviating associated mood disorders. Positive findings in related fields, like treatment for depression and addiction, highlight the necessity for more extensive clinical trials on psilocybin’s role in TBI recovery.